Vote Scores
Filings read through

Verona Pharma Plc: how funds voted at the meeting of 24 Apr 2025

Meeting
Season
year to 30 June 2025
Filers reporting
254
Ballot items
7

254 filers on Form N-PX reported votes at the Verona Pharma Plc meeting of 24 Apr 2025. The records fall into 7 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of Verona Pharma Plc has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2025. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    3 nominees. 96.7% of the reported votes are for. 6 filers withheld from or voted against at least one nominee.

    303 vote records from 74 filers. 1 of the 74 filers that marked the item voted against management.

    • Positions of 27 fund families
    • For 27
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    358 vote records from 253 filers. 160 of the 239 filers that marked the item voted against management. 14 filers gave no management mark.

    • Positions of 34 fund families
    • For 10
    • Against 24
    • Against management 24
  3. Item 3: Audit-related items (auditor ratification)

    201 vote records from 74 filers. 0 of the 74 filers that marked the item voted against management.

    • Positions of 27 fund families
    • For 27
  4. Item 4: CAPITAL STRUCTURE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    202 vote records from 74 filers. 0 of the 74 filers that marked the item voted against management.

    • Positions of 27 fund families
    • For 27
  5. Item 5: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    103 vote records from 76 filers. 57 of the 76 filers that marked the item voted against management.

    • Positions of 26 fund families
    • For 5
    • Against 21
    • Against management 21
  6. Item 6: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    88 vote records from 66 filers. 0 of the 66 filers that marked the item voted against management.

    • Positions of 26 fund families
    • For 26
  7. Item 7: OTHER: management items

    The company's items in this category are shown together, because filers word and number them differently.

    13 vote records from 8 filers. 0 of the 8 filers that marked the item voted against management.

    • Positions of one fund family
    • For 1

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Verona Pharma Plc, meeting of 24 Apr 2025Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor
AllianceBernsteinForNo report
AllspringAgainst, against managementFor
American CenturyAgainst, against managementFor
Artisan PartnersAgainst, against managementFor
BlackRock and iSharesAgainst, against managementFor
BNY MellonForNo report
Brighthouse FundsAgainst, against managementFor
Columbia ThreadneedleForFor
EquitableAgainst, against managementFor
Federated HermesForFor
FidelityAgainst, against managementFor
First TrustAgainst, against managementFor
Franklin TempletonAgainst, against managementFor
Goldman SachsForFor
Hartford FundsAgainst, against managementFor
InvescoForNo report
Janus HendersonForFor
John Hancock and ManulifeAgainst, against managementFor
Lord AbbettForFor
MassMutualAgainst, against managementFor
Morgan Stanley, Eaton Vance and CalvertAgainst, against managementNo report
NationwideAgainst, against managementFor
Natixis and Loomis SaylesAgainst, against managementFor
Neuberger BermanAgainst, against managementFor
Northern Trust and FlexSharesForNo report
Nuveen and TIAAForNo report
PGIM and PrudentialAgainst, against managementFor
PrincipalAgainst, against managementFor
ProShares and ProFundsAgainst, against managementFor
Russell InvestmentsAgainst, against managementFor
SEIAgainst, against managementNo report
T. Rowe PriceAgainst, against managementFor
VanguardAgainst, against managementFor
Victory CapitalAgainst, against managementFor

Questions

How many filers reported votes at the Verona Pharma Plc meeting?
254 Form N-PX filers reported votes at the meeting of 24 Apr 2025. On say-on-pay, 160 of 239 filers that marked the item voted against management (66.9%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Verona Pharma Plc reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Verona Pharma Plc with a meeting date within three days of 24 Apr 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .